Patents by Inventor Ahmed Mady

Ahmed Mady has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9884841
    Abstract: This invention is in the field of medicinal chemistry. In particular, the invention relates to a new class of small-molecules having benzoic acid structure which function as inhibitors of Mcl-1 protein, and their use as therapeutics for the treatment of cancer and other diseases.
    Type: Grant
    Filed: April 20, 2016
    Date of Patent: February 6, 2018
    Assignee: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Zaneta Nikolovska-Coleska, Jeanne A. Stuckey, Ahmed Mady, Lei Miao
  • Publication number: 20160304485
    Abstract: This invention is in the field of medicinal chemistry. In particular, the invention relates to a new class of small-molecules having benzoic acid structure which function as inhibitors of Mcl-1 protein, and their use as therapeutics for the treatment of cancer and other diseases.
    Type: Application
    Filed: April 20, 2016
    Publication date: October 20, 2016
    Inventors: Zaneta Nikolovska-Coleska, Jeanne A. Stuckey, Ahmed Mady, Lei Miao
  • Patent number: 9394303
    Abstract: This invention is in the field of medicinal chemistry. In particular, the invention relates to a new class of small-molecules having pyrazolopyridine structure which function as inhibitors of Mcl-1 protein, and their use as therapeutics for the treatment of cancer and other diseases.
    Type: Grant
    Filed: April 3, 2015
    Date of Patent: July 19, 2016
    Assignee: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Zaneta Nikolovska-Coleska, Fardokht Abulwerdi, Hollis Showalter, Lei Miao, Jeanne Stuckey, Ahmed Mady
  • Publication number: 20150284387
    Abstract: This invention is in the field of medicinal chemistry. In particular, the invention relates to a new class of small-molecules having pyrazolopyridine structure which function as inhibitors of Mcl-1 protein, and their use as therapeutics for the treatment of cancer and other diseases.
    Type: Application
    Filed: April 3, 2015
    Publication date: October 8, 2015
    Inventors: Zaneta Nikolovska-Coleska, Fardokht Abulwerdi, Hollis Showalter, Lei Miao, Jeanne Stuckey, Ahmed Mady